Global Azelastine 麻豆原创 Growth 2025-2031

Publication ID:

LPI04252381

Publication Date:

April 21, 2025

Pages:

105

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Azelastine market size is predicted to grow from US$ 454 million in 2025 to US$ 536 million in 2031; it is expected to grow at a CAGR of 2.8% from 2025 to 2031.
Azelastine is an antihistamine. It works by preventing the effects of a substance called histamine, which produced by the body. Histamine can cause itching, sneezing, runny nose, and watery eyes.
Azelastine is a medication primarily used as a nasal spray to treat hay fever and allergy symptoms including runny nose, sneezing, and itchy nose and as eye drops for allergic conjunctivitis. Other uses may include asthma and skin rashes for which is taken by mouth
Global Azelastine includes Viatris, Apotex, Yunfeng Pharma, Sun Pharma, Amneal Pharmaceuticals, Zhongsheng Pharma, Hikma Pharmaceuticals, Perrigo, Alkem Labs and Jiangxi Zhenshiming Pharmaceutical, etc. Global top 3 companies hold a share over 57%. Asia-Pacific is the largest market, with a share about 40%, followed by Europe and North America with the share approximately 20% each.
The 鈥淎zelastine Industry Forecast鈥� looks at past sales and reviews total world Azelastine sales in 2024, providing a comprehensive analysis by region and market sector of projected Azelastine sales for 2025 through 2031. With Azelastine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Azelastine industry.
This Insight Report provides a comprehensive analysis of the global Azelastine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Azelastine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Azelastine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Azelastine and breaks down the forecast by Type, by Distribution Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Azelastine.
This report presents a comprehensive overview, market shares, and growth opportunities of Azelastine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Nasal Spray
Eye Drops
Others
Segmentation by Distribution Channel:
Hospital
Retail Pharmacy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Viatris
Apotex
Yunfeng Pharma
Sun Pharma
Amneal Pharmaceuticals
Zhongsheng Pharma
Hikma Pharmaceuticals
Perrigo
Alkem Labs
Jiangxi Zhenshiming Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Azelastine market?
What factors are driving Azelastine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Azelastine market opportunities vary by end market size?
How does Azelastine break out by Type, by Distribution Channel?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Azelastine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Azelastine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Azelastine by Country/Region, 2020, 2024 & 2031
2.2 Azelastine Segment by Type
2.2.1 Nasal Spray
2.2.2 Eye Drops
2.2.3 Others
2.3 Azelastine Sales by Type
2.3.1 Global Azelastine Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Azelastine Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Azelastine Sale Price by Type (2020-2025)
2.4 Azelastine Segment by Distribution Channel
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Others
2.5 Azelastine Sales by Distribution Channel
2.5.1 Global Azelastine Sale 麻豆原创 Share by Distribution Channel (2020-2025)
2.5.2 Global Azelastine Revenue and 麻豆原创 Share by Distribution Channel (2020-2025)
2.5.3 Global Azelastine Sale Price by Distribution Channel (2020-2025)
3 Global by Company
3.1 Global Azelastine Breakdown Data by Company
3.1.1 Global Azelastine Annual Sales by Company (2020-2025)
3.1.2 Global Azelastine Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Azelastine Annual Revenue by Company (2020-2025)
3.2.1 Global Azelastine Revenue by Company (2020-2025)
3.2.2 Global Azelastine Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Azelastine Sale Price by Company
3.4 Key Manufacturers Azelastine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Azelastine Product Location Distribution
3.4.2 Players Azelastine Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Azelastine by Geographic Region
4.1 World Historic Azelastine 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Azelastine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Azelastine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Azelastine 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Azelastine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Azelastine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Azelastine Sales Growth
4.4 APAC Azelastine Sales Growth
4.5 Europe Azelastine Sales Growth
4.6 Middle East & Africa Azelastine Sales Growth
5 Americas
5.1 Americas Azelastine Sales by Country
5.1.1 Americas Azelastine Sales by Country (2020-2025)
5.1.2 Americas Azelastine Revenue by Country (2020-2025)
5.2 Americas Azelastine Sales by Type (2020-2025)
5.3 Americas Azelastine Sales by Distribution Channel (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Azelastine Sales by Region
6.1.1 APAC Azelastine Sales by Region (2020-2025)
6.1.2 APAC Azelastine Revenue by Region (2020-2025)
6.2 APAC Azelastine Sales by Type (2020-2025)
6.3 APAC Azelastine Sales by Distribution Channel (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Azelastine by Country
7.1.1 Europe Azelastine Sales by Country (2020-2025)
7.1.2 Europe Azelastine Revenue by Country (2020-2025)
7.2 Europe Azelastine Sales by Type (2020-2025)
7.3 Europe Azelastine Sales by Distribution Channel (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Azelastine by Country
8.1.1 Middle East & Africa Azelastine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Azelastine Revenue by Country (2020-2025)
8.2 Middle East & Africa Azelastine Sales by Type (2020-2025)
8.3 Middle East & Africa Azelastine Sales by Distribution Channel (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Azelastine
10.3 Manufacturing Process Analysis of Azelastine
10.4 Industry Chain Structure of Azelastine
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Azelastine Distributors
11.3 Azelastine Customer
12 World Forecast Review for Azelastine by Geographic Region
12.1 Global Azelastine 麻豆原创 Size Forecast by Region
12.1.1 Global Azelastine Forecast by Region (2026-2031)
12.1.2 Global Azelastine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Azelastine Forecast by Type (2026-2031)
12.7 Global Azelastine Forecast by Distribution Channel (2026-2031)
13 Key Players Analysis
13.1 Viatris
13.1.1 Viatris Company Information
13.1.2 Viatris Azelastine Product Portfolios and Specifications
13.1.3 Viatris Azelastine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Viatris Main Business Overview
13.1.5 Viatris Latest Developments
13.2 Apotex
13.2.1 Apotex Company Information
13.2.2 Apotex Azelastine Product Portfolios and Specifications
13.2.3 Apotex Azelastine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Apotex Main Business Overview
13.2.5 Apotex Latest Developments
13.3 Yunfeng Pharma
13.3.1 Yunfeng Pharma Company Information
13.3.2 Yunfeng Pharma Azelastine Product Portfolios and Specifications
13.3.3 Yunfeng Pharma Azelastine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Yunfeng Pharma Main Business Overview
13.3.5 Yunfeng Pharma Latest Developments
13.4 Sun Pharma
13.4.1 Sun Pharma Company Information
13.4.2 Sun Pharma Azelastine Product Portfolios and Specifications
13.4.3 Sun Pharma Azelastine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sun Pharma Main Business Overview
13.4.5 Sun Pharma Latest Developments
13.5 Amneal Pharmaceuticals
13.5.1 Amneal Pharmaceuticals Company Information
13.5.2 Amneal Pharmaceuticals Azelastine Product Portfolios and Specifications
13.5.3 Amneal Pharmaceuticals Azelastine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Amneal Pharmaceuticals Main Business Overview
13.5.5 Amneal Pharmaceuticals Latest Developments
13.6 Zhongsheng Pharma
13.6.1 Zhongsheng Pharma Company Information
13.6.2 Zhongsheng Pharma Azelastine Product Portfolios and Specifications
13.6.3 Zhongsheng Pharma Azelastine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Zhongsheng Pharma Main Business Overview
13.6.5 Zhongsheng Pharma Latest Developments
13.7 Hikma Pharmaceuticals
13.7.1 Hikma Pharmaceuticals Company Information
13.7.2 Hikma Pharmaceuticals Azelastine Product Portfolios and Specifications
13.7.3 Hikma Pharmaceuticals Azelastine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hikma Pharmaceuticals Main Business Overview
13.7.5 Hikma Pharmaceuticals Latest Developments
13.8 Perrigo
13.8.1 Perrigo Company Information
13.8.2 Perrigo Azelastine Product Portfolios and Specifications
13.8.3 Perrigo Azelastine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Perrigo Main Business Overview
13.8.5 Perrigo Latest Developments
13.9 Alkem Labs
13.9.1 Alkem Labs Company Information
13.9.2 Alkem Labs Azelastine Product Portfolios and Specifications
13.9.3 Alkem Labs Azelastine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Alkem Labs Main Business Overview
13.9.5 Alkem Labs Latest Developments
13.10 Jiangxi Zhenshiming Pharmaceutical
13.10.1 Jiangxi Zhenshiming Pharmaceutical Company Information
13.10.2 Jiangxi Zhenshiming Pharmaceutical Azelastine Product Portfolios and Specifications
13.10.3 Jiangxi Zhenshiming Pharmaceutical Azelastine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Jiangxi Zhenshiming Pharmaceutical Main Business Overview
13.10.5 Jiangxi Zhenshiming Pharmaceutical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.